Adrenergic blocking agents

Immunogen 14 amino acids near the carboxy terminus of human IA-6. Application Used as a blocking peptide in immunoblotting applications.

Immunogen 20 amino amino terminus of mouse ICAD. Application Used as a blocking peptide in immunoblotting applications.

Immunogen 20 amino acids near the carboxy terminus of mouse ICAD. Application Used as a blocking peptide in immunoblotting applications.

InformationIcatibant Acetate Icatibant Acetate acts as an antagonist of the bradykinin B2 receptor and is used in the treatment of hereditary angioedema.Targetsbradykinin B2 receptorIn vitroIcatibant is a decapeptide resistant to the

A potent, selective antagonist of the &beta2-adrenergic receptor (Ki = 0.7 nM for the &beta2 receptor, compared with 49.

A potent, selective antagonist of the &beta2-adrenergic receptor (Ki = 0.7 nM for the &beta2 receptor, compared with 49.

A highly selective antagonist for the &#9462 adrenergic receptors. Binds to the &#9462 subtype with at least 100 times greater affinity than &#9461 or &#9463, the two other known subtypes of the beta adrenoceptor.

ICI 89406 is known to be a β-adrenergic antagonist.

ICI 89406 is known to be a β-adrenergic antagonist.

InformationICI-118551 is a highly selectiveβ2-adrenergic receptor antagonistwithKivalues of 0.7, 49.5 and 611 nM for β2, β1 and β3 receptors, respectively.Targetsβ2-adrenergic receptor (Cell-free assay): β1-adrenergic receptor (Cell-free assay):

InformationICI-118551 is a highly selectiveβ2-adrenergic receptor antagonistwithKivalues of 0.7, 49.5 and 611 nM for β2, β1 and β3 receptors, respectively.Targetsβ2-adrenergic receptor (Cell-free assay): β1-adrenergic receptor (Cell-free assay):

InformationICI-118551 is a highly selectiveβ2-adrenergic receptor antagonistwithKivalues of 0.7, 49.5 and 611 nM for β2, β1 and β3 receptors, respectively.Targetsβ2-adrenergic receptor (Cell-free assay): β1-adrenergic receptor (Cell-free assay):